Skip to content
CJC-1295 Pharmacy

An independent reading of the CJC-1295 research record — what the trials show, what the compounding-pharmacy literature claims, and where the published evidence ends.

§ N° VIII · Contact

Contact CJC-1295 Pharmacy

Editorial correspondence only — corrections to citations, requests for additional literature, notes on the dossier method. No clinical or commercial inquiries.

Editorial correspondence

CJC-1295 Pharmacy takes editorial correspondence by email: corrections to citations, requests that we cover an additional published study, observations about the dossier method, or a note from a peer researcher flagging a paper we have missed. We reply when we can. Questions about dose, protocol, or where to buy go unanswered, and nothing here stands in for a clinician.

There are no referrals to hand out — not to compounding pharmacies, not to clinics or telehealth services, not to peptide vendors. The dossier holds no relationship with any commercial entity in the peptide trade; its only tie is to the published literature.

What we cannot do

We cannot recommend a dose. We cannot prescribe. We cannot fill a script. The 'pharmacy' in our domain name is editorial framing, not a service offering — the position the publisher occupies relative to the compounding-pharmacy literature, not a commercial pharmacy.

For clinical questions about growth-hormone-axis therapy, the appropriate resource is a licensed endocrinologist with access to the patient's full medical history. For regulatory questions about the FDA 503A compounding status of CJC-1295, the FDA Pharmacy Compounding Advisory Committee briefing materials and the September 2024 Category 2 action are the canonical public-record sources [14][17]. For WADA-prohibited-list questions, the 2026 list document on the WADA website is the source of record [15].

Contact form

A simple editorial contact form is provided below. Required fields: name, email, message. We read every submission; we cannot promise a reply to every one. Please indicate in the subject line whether your message is a citation correction, a literature suggestion, or a method note.